Approved Inhalation Products
Using its proprietary drug delivery technologies, SkyePharma develops new formulations of existing pharmaceutical products as well as new chemical entities to provide a clinical benefit to patients.
There are two approved products in the area of inhalation drug delivery that incorporate the Group’s proven proprietary technologies. The Group’s products are marketed in a number of countries throughout the world by leading and speciality pharmaceutical companies.
Copyright 2008, SkyePharma. All Rights Reserved.
SkyePharma PLC is a public limited company registered in England and Wales, registration number 0107582.
Registered office: 105 Piccadilly, London, W1J 7NJ, United Kingdom
